Pavel, Ana B.
University of Mississippi · Icahn School of Medicine at Mount Sinai
11 papers on CoChatORCID 0000-0002-0497-8351
Most cited papers
- Verified
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Guttman-Yassky, E., Brunner, P. M., Neumann, A. U., Khattri, S., Pavel, A. B., Malik, K., Singer, G. K., Baum, D., Gilleaudeau, P., Sullivan-Whalen, M., et al. (2018) · Journal of the American Academy of Dermatology
Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis
Cited by 343
- Verified
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
Guttman-Yassky, E., Pavel, A. B., Zhou, L., Estrada, Y. D., Zhang, N., Xu, H., Peng, X., Wen, H.-C., Govas, P., Gudi, G., et al. (2019) · Journal of Allergy and Clinical Immunology
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 220
- Verified
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults
Renert-Yuval, Y., Del Duca, E., Pavel, A. B., Fang, M., Lefferdink, R., Wu, J., Diaz, A., Estrada, Y. D., Canter, T., Zhang, N., et al. (2021) · Journal of Allergy and Clinical Immunology
Dermatology and Skin DiseasesContact Dermatitis and Allergies
Cited by 168
- Verified
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis
Zhou, L., Leonard, A., Pavel, A. B., Malik, K., Raja, A., Glickman, J., Estrada, Y. D., Peng, X., del Duca, E., Sanz-Cabanillas, J., et al. (2019) · Journal of Allergy and Clinical Immunology
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 146
- Verified
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis
Simpson, E. L., Imafuku, S., Poulin, Y., Ungar, B., Zhou, L., Malik, K., Wen, H.-C., Xu, H., Estrada, Y. D., Peng, X., et al. (2019) · Journal of Investigative Dermatology
Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis
Cited by 120
- Verified
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis
Ungar, B., Pavel, A. B., Li, R., Kimmel, G., Nia, J., Hashim, P., Kim, H. J., Chima, M., Vekaria, A. S., Estrada, Y., et al. (2021) · Journal of Allergy and Clinical Immunology
Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis
Cited by 119
- Verified
Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood
Czarnowicki, T., He, H., Canter, T., Han, J., Lefferdink, R., Erickson, T., Rangel, S., Kameyama, N., Kim, H. J., Pavel, A. B., et al. (2020) · Journal of Allergy and Clinical Immunology
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 118
- Verified
Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features
Chan, T. C., Sanyal, R. D., Pavel, A. B., Glickman, J., Zheng, X., Xu, H., Cho, Y.-T., Tsai, T.-F., Wen, H.-C., Peng, X., et al. (2018) · Journal of Allergy and Clinical Immunology
Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis
Cited by 114
- Verified
The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease
Brunner, P. M., He, H., Pavel, A. B., Czarnowicki, T., Lefferdink, R., Erickson, T., Canter, T., Puar, N., Rangel, S. M., Malik, K., et al. (2019) · Journal of the American Academy of Dermatology
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 109
- Verified
A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis
Piscitelli, S. C., Pavel, A. B., McHale, K., Jett, J. E., Collins, J., Gillmor, D., Tabolt, G., Li, R., Song, T., Zhang, N., et al. (2021) · Journal of Investigative Dermatology
Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis
Cited by 30
- Verified
563 ATx201 modulates biomarkers of skin barrier function and cutaneous inflammation in patients with moderate atopic dermatitis
Guttman-Yassky, E., Bissonnette, R., Pavel, A., Saint-Cyr Proulx, E., Prokocimer, P., Toft-Kehler, R., & Sommer, M. (2020) · Journal of Investigative Dermatology
Dermatology and Skin DiseasesContact Dermatitis and Allergies
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free